Comment on ‘Risk of inflammatory dermatoses following COVID-19 infection: a cohort study of 204,241 patients’: considerations regarding causal inference

Clicks: 3
ID: 316912
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #152 of 176 articles by views in clinical and experimental dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 176 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Our correspondence discusses an important interpretive consideration regarding the distinction between persistent response among selected responders and durable disease control in the broader treated population in a recent study of long-term lebrikizumab efficacy in atopic dermatitis. We highlight how responder-enriched analyses, attrition, and treatment persistence may influence interpretation of long-term stability outcomes and encourage cautious interpretation of durability claims in chronic inflammatory skin disease.
Reference Key
openalex_W7164169521 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Xue Xu, Rongying Wang, Qianqian Zhang, Yulin Zou
Journal clinical and experimental dermatology
Year 2026
DOI
10.1093/ced/llag245
URL
https://doi.org/10.1093/ced/llag245
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.